United States · FDA National Drug Code directory
BRENZAVVY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82381-2174_e4847454-8b05-4a77-9ed8-0d1d273738fe
- Product NDC
- 82381-2174
- Form
- TABLET
- Composition / generic term
- Bexagliflozin
- Labeler
- TheracosBio, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230713
- Source listing expiry
- 20271231
Source-listed ingredients
- BEXAGLIFLOZIN — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (82381-2174-1) · 82381-2174-1
- 90 TABLET in 1 BOTTLE (82381-2174-2) · 82381-2174-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →